{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:24:54Z","timestamp":1787340294348,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Breast cancer is a significant public health concern in Jordan. It is the most common cancer among Jordanian women. Despite its high incidence and advanced stage at time of diagnosis, the uptake of breast cancer screening in Jordan is low. This study aims to compare clinical outcomes of both screening and diagnostic mammogram among women in Jordan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 1005 women who underwent mammography in breast imaging unit in a tertiary hospital in Jordan. It aimed to investigate outcomes of screening and diagnostic mammography. recall rates, clinical manifestations and cancer rates were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1005 participants were involved and divided into screening group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009634) and diagnostic group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009371). Women in the diagnostic group were more likely to be younger, premenopausal, smokers with higher BMI. Among the screening group, 22.3% were labeled with abnormal mammogram, 26% recalled for ultrasound, 46 patients underwent tissue biopsy and a total of 12 patients had a diagnosis of breast carcinoma. Among the diagnostic group, the most commonly reported symptoms were a feeling of breast mass, mastalgia and nipple discharge. Abnormal mammogram was reported in 50.4% of women, a complementary ultrasound was performed for 205 patients. A diagnostic Tru-cut biopsy for 144 patients and diagnostic excisional biopsy for 17 patients were performed. A total of 131 had a diagnosis of carcinoma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With the high possibility of identifying a carcinoma in mammography among symptomatic women and low uptake of screening mammogram, efforts to increase awareness and improve access to screening services are crucial in reducing the burden of breast cancer in Jordan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-024-03007-0","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T05:01:42Z","timestamp":1710997302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcomes of screening and diagnostic mammography in a limited resource healthcare system"],"prefix":"10.1186","volume":"24","author":[{"given":"Mahmoud","family":"Al-Balas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzeh","family":"Al-Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"AlAmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"Al-Taweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Ghabboun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farh","family":"Al Bzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaia","family":"Abumkarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala Abu","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Eleiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"3007_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-030-20301-6_2","volume":"1152","author":"SS Coughlin","year":"2019","unstructured":"Coughlin SS. Epidemiology of breast Cancer in women. Adv Exp Med Biol. 2019;1152:9\u201329. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_2.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"3007_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183\u201394. https:\/\/doi.org\/10.1002\/cac2.12207.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"3007_CR3","first-page":"133","volume":"117","author":"K Farrell","year":"2020","unstructured":"Farrell K, Bennett DL, Schwartz TL. Screening for breast Cancer: what you need to know. Mo Med. 2020;117(2):133\u20135.","journal-title":"Mo Med"},{"key":"3007_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/aam.aam_17_20","volume":"20","author":"H \u200bKolade-Yunusa","year":"2021","unstructured":"\u200bKolade-Yunusa H, Itanyi U. Outcome of mammography examination in asymptomatic women. Ann Afr Med. 2021;20:52. https:\/\/doi.org\/10.4103\/aam.aam_17_20.","journal-title":"Ann Afr Med"},{"key":"3007_CR5","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.32859","volume":"126","author":"SW \u200bDuffy","year":"2020","unstructured":"\u200bDuffy SW, Tab\u00e1r L, Yen AM, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126:2971\u20139. https:\/\/doi.org\/10.1002\/cncr.32859.","journal-title":"Cancer"},{"issue":"23","key":"3007_CR6","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.3390\/cancers13235916","volume":"13","author":"T \u200bMahmood","year":"2021","unstructured":"\u200bMahmood T, Li J, Pei Y, Akhtar F, Imran A, Yaqub M. An Automatic Detection and Localization of Mammographic microcalcifications ROI with Multi-scale features using the Radiomics Analysis Approach. Cancers (Basel). 2021;13(23):5916. https:\/\/doi.org\/10.3390\/cancers13235916. Published 2021 Nov 24.","journal-title":"Cancers (Basel)"},{"key":"3007_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/smj.smj_44_16","volume":"22","author":"S \u200bMuhammad","year":"2019","unstructured":"\u200bMuhammad S, Saidu S, Ma\u2019aji S, Musa A, Ibrahim H, Gusau S, Shirama Y. Mammographic screening patterns in Sokoto, Northwestern Nigeria. Sahel Med J. 2019;22:23. https:\/\/doi.org\/10.4103\/smj.smj_44_16.","journal-title":"Sahel Med J"},{"issue":"4","key":"3007_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cpet.2023.04.003","volume":"18","author":"AR \u200bGegios","year":"2023","unstructured":"\u200bGegios AR, Peterson MS, Fowler AM. Breast Cancer screening and diagnosis: recent advances in imaging and current limitations. PET Clin. 2023;18(4):459\u201371. https:\/\/doi.org\/10.1016\/j.cpet.2023.04.003.","journal-title":"PET Clin"},{"key":"3007_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13244-016-0531-4","volume":"8","author":"F \u200bSardanelli","year":"2017","unstructured":"\u200bSardanelli F, Fallenberg EM, Clauser P, Trimboli RM, Camps-Herrero J, Helbich TH, Forrai G. Mammography: an update of the EUSOBI recommendations on information for women. Insights Imaging. 2017;8:11\u20138. https:\/\/doi.org\/10.1007\/s13244-016-0531-4.","journal-title":"Insights Imaging"},{"issue":"1","key":"3007_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rcl.2020.09.009","volume":"59","author":"K \u200bFunaro","year":"2021","unstructured":"\u200bFunaro K, Ataya D, Niell B. Understanding the Mammography audit. Radiol Clin North Am. 2021;59(1):41\u201355. https:\/\/doi.org\/10.1016\/j.rcl.2020.09.009.","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"3007_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1188\/19.CJON.281-287","volume":"23","author":"TE \u200bSmalls","year":"2019","unstructured":"\u200bSmalls TE, Heiney SP, Baliko B, Tavakoli AS. Mammography Adherence: creation of a process change plan to increase usage rates. Clin J Oncol Nurs. 2019;23(3):281\u20137. https:\/\/doi.org\/10.1188\/19.CJON.281-287.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"3007_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamaoncol.2023.4519","volume":"10","author":"X \u200bMao","year":"2024","unstructured":"\u200bMao X, He W, Humphreys K, et al. Breast Cancer incidence after a false-positive mammography result. JAMA Oncol. 2024;10(1):63\u201370. https:\/\/doi.org\/10.1001\/jamaoncol.2023.4519.","journal-title":"JAMA Oncol"},{"issue":"7","key":"3007_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/cncr.34078","volume":"128","author":"KM \u200bTsuruda","year":"2022","unstructured":"\u200bTsuruda KM, Larsen M, Rom\u00e1n M, Hofvind S. Cumulative risk of a false-positive screening result: a retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway. Cancer. 2022;128(7):1373\u201380. https:\/\/doi.org\/10.1002\/cncr.34078.","journal-title":"Cancer"},{"issue":"3","key":"3007_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"\u200b[14] Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"3007_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bpobgyn.2022.03.018","volume":"83","author":"LA Newman","year":"2022","unstructured":"\u200b[15] Newman LA. Breast cancer screening in low and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2022;83:15\u201323. https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.03.018.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"3007_CR16","first-page":"1568","volume":"10","author":"FZ \u200bFrancies","year":"2020","unstructured":"\u200bFrancies FZ, Hull R, Khanyile R, Dlamini Z. Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. Am J Cancer Res. 2020;10(5):1568\u201391. Published 2020 May 1.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"3007_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10549-017-4408-0","volume":"166","author":"KE \u200bLukong","year":"2017","unstructured":"\u200bLukong KE, Ogunbolude Y, Kamdem JP. Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast Cancer Res Treat. 2017;166(2):351\u201365. https:\/\/doi.org\/10.1007\/s10549-017-4408-0.","journal-title":"Breast Cancer Res Treat"},{"key":"3007_CR18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22464","author":"N Huang","year":"2022","unstructured":"Huang N, Chen L, He J, Nguyen QD. The efficacy of clinical breast exams and breast self-exams in detecting malignancy or positive ultrasound findings. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.22464.","journal-title":"Cureus"},{"issue":"5","key":"3007_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/jjco\/hyw008","volume":"46","author":"C \u200bHamashima","year":"2016","unstructured":"\u200bHamashima C, Japanese Research Group for the Development of Breast Cancer Screening Guidelines, Hamashima CC, et al. The Japanese guidelines for breast Cancer screening. Jpn J Clin Oncol. 2016;46(5):482\u201392. https:\/\/doi.org\/10.1093\/jjco\/hyw008.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"3007_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/ijc.32211","volume":"145","author":"O \u200bMandrik","year":"2019","unstructured":"\u200bMandrik O, Zielonke N, Meheus F, et al. Systematic reviews as a \u2018lens of evidence\u2019: determinants of benefits and harms of breast cancer screening. Int J Cancer. 2019;145(4):994\u20131006. https:\/\/doi.org\/10.1002\/ijc.32211.","journal-title":"Int J Cancer"},{"key":"3007_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1186\/s12885-020-07521-w","volume":"20","author":"TT Ngan","year":"2020","unstructured":"Ngan TT, Nguyen NTQ, Van Minh H, et al. Effectiveness of clinical breast examination as a \u2018stand-alone\u2019 screening modality: an overview of systematic reviews. BMC Cancer. 2020;20:1070. https:\/\/doi.org\/10.1186\/s12885-020-07521-w.","journal-title":"BMC Cancer"},{"issue":"2","key":"3007_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1257\/jep.35.2.119","volume":"35","author":"AE \u200bKowalski","year":"2021","unstructured":"\u200bKowalski AE. Mammograms and Mortality: how has the evidence evolved? J Econ Perspect. 2021;35(2):119\u201340. https:\/\/doi.org\/10.1257\/jep.35.2.119.","journal-title":"J Econ Perspect"},{"issue":"1","key":"3007_CR23","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1038\/s41598-019-46736-1","volume":"9","author":"Y Li","year":"2019","unstructured":"Li Y, Zhou Y, Mao F, et al. The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer. Sci Rep. 2019;9(1):10158. https:\/\/doi.org\/10.1038\/s41598-019-46736-1.","journal-title":"Sci Rep"},{"key":"3007_CR24","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41416-023-02156-7","volume":"128","author":"DP French","year":"2023","unstructured":"French DP, McWilliams L, Bowers S, et al. Psychological impact of risk-stratified screening as part of the NHS breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420). Br J Cancer. 2023;128:1548\u201358. https:\/\/doi.org\/10.1038\/s41416-023-02156-7.","journal-title":"Br J Cancer"},{"key":"3007_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12885-015-1419-2","volume":"15","author":"YC \u200bTeh","year":"2015","unstructured":"\u200bTeh YC, Tan GH, Taib NA, Rahmat K, Westerhout CJ, Fadzli F, See MH, Jamaris S, Yip CH. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system. BMC Cancer. 2015;15:405. https:\/\/doi.org\/10.1186\/s12885-015-1419-2.","journal-title":"BMC Cancer"},{"key":"3007_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1200\/JGO.19.00279","volume":"6","author":"H Abdel-Razeq","year":"2020","unstructured":"Abdel-Razeq H, Mansour A, Jaddan D. Breast Cancer Care in Jordan. JCO Glob Oncol. 2020;6:260\u20138. https:\/\/doi.org\/10.1200\/JGO.19.00279. PMID: 32083950; PMCID: PMC7051801.","journal-title":"JCO Glob Oncol"},{"issue":"5","key":"3007_CR27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jiph.2019.06.001","volume":"12","author":"M Ibrahim","year":"2019","unstructured":"Ibrahim M. Gosadi. National screening programs in Saudi Arabia: overview, outcomes, and effectiveness. J Infect Public Health Volume. 2019;12(5):608\u201314. https:\/\/doi.org\/10.1016\/j.jiph.2019.06.001.","journal-title":"J Infect Public Health Volume"},{"issue":"4","key":"3007_CR28","doi-asserted-by":"publisher","first-page":"e0124850","DOI":"10.1371\/journal.pone.0124850","volume":"10","author":"C El Bcheraoui","year":"2015","unstructured":"El Bcheraoui C, Basulaiman M, Wilson S, Daoud F, Tuffaha M, AlMazroa MA, Memish ZA, Al Saeedi M, Mokdad AH. Breast Cancer Screening in Saudi Arabia: free but almost no takers. PLoS ONE. 2015;10(4):e0124850. https:\/\/doi.org\/10.1371\/journal.pone.0124850.","journal-title":"PLoS ONE"},{"key":"3007_CR29","doi-asserted-by":"publisher","unstructured":"Rivera-Franco MM, Leon-Rodriguez E. Delays in Breast Cancer Detection and Treatment in Developing Countries [published correction appears in Breast Cancer (Auckl). 2019;13:1178223419834790]. Breast Cancer (Auckl). 2018;12:1178223417752677. https:\/\/doi.org\/10.1177\/1178223417752677.","DOI":"10.1177\/1178223417752677"},{"issue":"3","key":"3007_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5306\/wjco.v5.i3.465","volume":"5","author":"K Unger-Salda\u00f1a","year":"2014","unstructured":"Unger-Salda\u00f1a K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465\u201377. https:\/\/doi.org\/10.5306\/wjco.v5.i3.465.","journal-title":"World J Clin Oncol"},{"issue":"5","key":"3007_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.breast.2005.07.002","volume":"14","author":"S Boulos","year":"2005","unstructured":"Boulos S, Gadallah M, Neguib S, Essam EA, Youssef A, Costa A, Mittra I, Miller AB. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast. 2005;14(5):340\u20136. https:\/\/doi.org\/10.1016\/j.breast.2005.07.002.","journal-title":"Breast"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03007-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T05:02:32Z","timestamp":1710997352000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03007-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3007"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03007-0","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The statement of ethical approval was obtained from the Institutional Review Board (IRB) committee at Hashemite University No.5\/6\/2020\/2021 and Prince Hamza Hospital. The need for written informed consent was waived by the IRB ethics committee due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identifiable data for participants is included in the results. The need for written informed consent was waived by the IRB ethics committee due to the retrospective nature of the study, IRB number No.5\/6\/2020\/2021. Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A major limitation of this study is its single-center-based design, as well as its retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study limitations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}